E. Thomas Corcoran, Director at PHIBRO ANIMAL HEALTH CORP (PAHC), bought 10,000 shares at $31.77 ($318K) on 2026-05-29, disclosed to the SEC on 2026-06-02.
Director E. Thomas Corcoran purchased 10,000 shares at $31.77, representing the largest insider purchase in the company's history. This aggressive bet comes as the stock has plummeted 45.67% over the last 30 days, suggesting insiders see value at current depressed levels.
PAHC is currently trading at $29.86, having crashed 45.67% over the last 30 days and sitting 50.3% below its 52-week high of $60.08.
Upcoming catalysts include the Q3 2026 earnings transcript release on June 1, 2026, and a surge in implied volatility for stock options on May 29, 2026. Additionally, the trade itself serves as a catalyst, as this represents the largest insider purchase in the company's history.
A recent article on May 23, 2026, highlighted a 'notable insider sale' amidst a CEO transition, suggesting potential internal uncertainty. Furthermore, a cautionary piece on May 28, 2026, flagged stocks under $50 as carrying less stability than larger peers.
Clearly above the average filing.
| Filing → |
| PAHC | BUY | 2021-09-01 | $118K | — | Filing → |
| PAHC | BUY | 2019-09-04 | $106K | — | Filing → |
| PAHC | BUY | 2016-05-23 | $91K | — | Filing → |